20-33226471-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_178466.5(BPIFA3):c.602C>T(p.Pro201Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00272 in 1,609,456 control chromosomes in the GnomAD database, including 71 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0096 ( 20 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 51 hom. )
Consequence
BPIFA3
NM_178466.5 missense
NM_178466.5 missense
Scores
2
4
12
Clinical Significance
Conservation
PhyloP100: 2.97
Genes affected
BPIFA3 (HGNC:16204): (BPI fold containing family A member 3) Predicted to enable lipid binding activity. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008552313).
BP6
Variant 20-33226471-C-T is Benign according to our data. Variant chr20-33226471-C-T is described in ClinVar as [Benign]. Clinvar id is 3037591.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00963 (1465/152078) while in subpopulation EAS AF= 0.0351 (182/5186). AF 95% confidence interval is 0.0309. There are 20 homozygotes in gnomad4. There are 699 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BPIFA3 | NM_178466.5 | c.602C>T | p.Pro201Leu | missense_variant | 5/7 | ENST00000375454.8 | NP_848561.2 | |
BPIFA3 | NM_001042439.2 | c.494C>T | p.Pro165Leu | missense_variant | 4/6 | NP_001035904.1 | ||
BPIFA3 | XR_244132.4 | n.829C>T | non_coding_transcript_exon_variant | 5/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BPIFA3 | ENST00000375454.8 | c.602C>T | p.Pro201Leu | missense_variant | 5/7 | 5 | NM_178466.5 | ENSP00000364603.3 | ||
BPIFA3 | ENST00000375452.3 | c.494C>T | p.Pro165Leu | missense_variant | 4/6 | 1 | ENSP00000364601.3 | |||
BPIFA3 | ENST00000490499.5 | n.2139C>T | non_coding_transcript_exon_variant | 5/7 | 1 | |||||
BPIFA3 | ENST00000471233.1 | n.812C>T | non_coding_transcript_exon_variant | 5/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00955 AC: 1451AN: 151960Hom.: 19 Cov.: 32
GnomAD3 genomes
AF:
AC:
1451
AN:
151960
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00493 AC: 1225AN: 248580Hom.: 13 AF XY: 0.00422 AC XY: 566AN XY: 134248
GnomAD3 exomes
AF:
AC:
1225
AN:
248580
Hom.:
AF XY:
AC XY:
566
AN XY:
134248
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00200 AC: 2910AN: 1457378Hom.: 51 Cov.: 30 AF XY: 0.00190 AC XY: 1374AN XY: 724970
GnomAD4 exome
AF:
AC:
2910
AN:
1457378
Hom.:
Cov.:
30
AF XY:
AC XY:
1374
AN XY:
724970
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00963 AC: 1465AN: 152078Hom.: 20 Cov.: 32 AF XY: 0.00941 AC XY: 699AN XY: 74308
GnomAD4 genome
AF:
AC:
1465
AN:
152078
Hom.:
Cov.:
32
AF XY:
AC XY:
699
AN XY:
74308
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
127
ESP6500EA
AF:
AC:
6
ExAC
AF:
AC:
645
Asia WGS
AF:
AC:
50
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
BPIFA3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 31, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at